ImmunitasBio Private Limited
There is a definitive need for an accurate screening tool for early identification of high-risk CD populations and a monitoring tool to follow up on Celiac disease treatment & assessment.
With Biotech Ignition Grant, Immunitas Bio aims to develop a test that can identify CD-specific T-cells in whole blood without invasive clinical procedures.